A suggested modification to FIGO stage I endometrial cancer. (Q53062390)

11 May 2018

title

A suggested modification to FIGO stage I endometrial cancer. (English)

1 reference

11 May 2018

author

Roman Rouzier

8

1 reference

11 May 2018

Martin Koskas

9

1 reference

11 May 2018

Françoise Clavel-Chapelon

4

Françoise Clavel-Chapelon

1 reference

11 May 2018

7

Emile Darai

1 reference

11 May 2018

Olivier Graesslin

2

Olivier Graesslin

1 reference

11 May 2018

Dominique Luton

6

Dominique Luton

1 reference

11 May 2018

Bassam Haddad

5

Bassam Haddad

1 reference

11 May 2018

Emmanuel Barranger

3

Emmanuel Barranger

1 reference

11 May 2018

Patrick Aristizabal

1

Patrick Aristizabal

1 reference

11 May 2018

language of work or name

English

0 references

publication date

12 March 2014

1 reference

11 May 2018

published in

Gynecologic Oncology

1 reference

11 May 2018

volume

133

1 reference

11 May 2018

issue

2

1 reference

11 May 2018

page(s)

192-196

1 reference

11 May 2018

Gynecologic Cancer Intergroup (GCIG) proposals for changes of the current FIGO staging system

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.03.009

Prognostic value of the 2009 FIGO staging for endometrial cancer: an illustration of the E3N cohort

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.03.009

Comparative performance of the 2009 International Federation of Gynecology and Obstetrics' staging system for uterine corpus cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.03.009

Comparative performance of the 2009 international Federation of gynecology and obstetrics' staging system for uterine corpus cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.03.009

Gene expression patterns related to vascular invasion and aggressive features in endometrial cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.03.009

Stage I, grade 3 endometrioid adenocarcinoma of the endometrium: an analysis of clinical outcomes and patterns of recurrence

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.03.009

Nomograms to predict isolated loco-regional or distant recurrence among women with uterine cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.03.009

Comparative outcomes assessment of uterine grade 3 endometrioid, serous, and clear cell carcinomas.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.03.009

Lymphovascular space invasion is an independent risk factor for nodal disease and poor outcomes in endometrioid endometrial cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.03.009

Risk-scoring system for the individualized prediction of lymphatic dissemination in patients with endometrioid endometrial cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.03.009

Lymphovascular space invasion (LVSI) is an isolated poor prognostic factor for recurrence and survival among women with intermediate- to high-risk early-stage endometrioid endometrial cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.03.009

Diagnosis and staging of penile cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.03.009

Testicular non-seminoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.03.009

Endometrial carcinoma: ESMO clinical recommendations for diagnosis, treatment and follow-up

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.03.009

Lymphovascular space involvement in early stage well-differentiated endometrial cancer is associated with increased mortality

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.03.009

Accuracy of frozen-section diagnosis at surgery in clinical stage I and II endometrial carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.03.009

A prospective blinded evaluation of the accuracy of frozen section for the surgical management of endometrial cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.03.009

Frozen section analyses as predictors of lymphatic spread in patients with early-stage uterine cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.03.009

A prospective assessment of the reliability of frozen section to direct intraoperative decision making in endometrial cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.03.009

Frozen section underestimates the need for surgical staging in endometrial cancer patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.03.009

Endometrial cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.03.009

Clinical practice guidelines for the management of patients with endometrial cancer in France: recommendations of the Institut National du Cancer and the Société Française d'Oncologie Gynécologique.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.03.009

Impact of lymphovascular space invasion on a nomogram for predicting lymph node metastasis in endometrial cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.03.009

Efficacy of systematic pelvic lymphadenectomy in endometrial cancer (MRC ASTEC trial): a randomised study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.03.009

Systematic pelvic lymphadenectomy vs. no lymphadenectomy in early-stage endometrial carcinoma: randomized clinical trial.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.03.009

Retrospective Analysis of Selective Lymphadenectomy in Apparent Early-Stage Endometrial Cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.03.009

FIGO stage IIIC endometrial carcinoma: resection of macroscopic nodal disease and other determinants of survival

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.03.009

Surgery and postoperative radiotherapy versus surgery alone for patients with stage-1 endometrial carcinoma: multicentre randomised trial. PORTEC Study Group. Post Operative Radiation Therapy in Endometrial Carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.03.009

A phase III trial of surgery with or without adjunctive external pelvic radiation therapy in intermediate risk endometrial adenocarcinoma: a Gynecologic Oncology Group study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.03.009

Adjuvant external beam radiotherapy in the treatment of endometrial cancer (MRC ASTEC and NCIC CTG EN.5 randomised trials): pooled trial results, systematic review, and meta-analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.03.009

Vaginal brachytherapy versus pelvic external beam radiotherapy for patients with endometrial cancer of high-intermediate risk (PORTEC-2): an open-label, non-inferiority, randomised trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.03.009

10.1016/J.YGYNO.2014.03.009

7 January 2021

Identifiers

DOI

1 reference

11 May 2018

PubMed ID

24631453

1 reference

11 May 2018